GHRL and gastroparesis: Several clinical studies have assessed the therapeutic potential of ghrelin mimetics, such as anamorelin (RC-1291) (52), ulimorelin (TZP-101) (60–62), and RM-131 (44, 45) for the treatment of cachexia, gastroparesis, and gastric/intestinal dysmobility disorders.